Beximco Pharmaceuticals Ltd. GDR | Balance Sheet
Fiscal year is July-June. All values BDT Millions.
2012
2013
2014
2016
2017
2018
Cash & Short Term Investments
3,240
3,684
2,726
1,663
1,188
760
Total Accounts Receivable
1,360
1,314
1,468
1,701
2,187
2,902
Inventories
3,160
3,255
3,470
3,780
4,574
6,459
Other Current Assets
438
651
702
1,384
1,183
1,224
Total Current Assets
8,197
8,903
8,366
8,528
9,131
11,344
Net Property, Plant & Equipment
16,202
18,364
20,393
22,236
24,472
30,525
Total Investments and Advances
3
5
6
5
18
37
Intangible Assets
187
198
235
380
463
1,827
Total Assets
24,590
27,471
29,001
31,149
34,084
43,739
ST Debt & Current Portion LT Debt
2,191
3,531
3,817
2,030
1,956
Accounts Payable
141
123
202
145
387
Income Tax Payable
274
326
368
347
421
Other Current Liabilities
459
402
320
461
643
Total Current Liabilities
3,065
4,383
4,708
2,983
3,406
Long-Term Debt
1,470
1,151
902
2,366
2,636
Provision for Risks & Charges
500
611
742
984
1,117
Deferred Taxes
1,147
1,551
1,729
1,757
1,853
Total Liabilities
6,182
7,695
8,080
8,089
9,012
Common Equity (Total)
18,408
19,776
20,920
23,059
25,072
Total Shareholders' Equity
18,408
19,776
20,920
23,059
25,072
Total Equity
18,408
19,776
20,920
23,059
25,072
Liabilities & Shareholders' Equity
24,590
27,471
29,001
31,149
34,084
About Beximco Pharmaceuticals
View Profile
